Gupta Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Gupta Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$15K	Buy	109 +5	+5%	+$734	﹤0.01%	762
2015 Q4	$20K	Buy	+104	New	+$18.2K	0.01%	668
2015 Q3	–	Sell	-7	Closed	-$1K	–	1374
2015 Q2	$1K	Hold	7	–	–	﹤0.01%	1227
2015 Q1	$1K	Buy	+7	New	+$1.27K	﹤0.01%	1124

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Gupta Wealth Management's ALXN Position: Q1 2016 in Review

Gupta Wealth Management increased its Alexion Pharmaceuticals (ALXN) stake by 4.8% in Q1 2016, buying an estimated $734 and bringing the position to 109 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Gupta Wealth Management first reported a position in ALXN in Q1 2015 and has held it in 4 quarters since. The position peaked at $20K in Q4 2015. 520 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

Gupta Wealth Management held 109 shares of Alexion Pharmaceuticals worth $15K as of Q1 2016.
Gupta Wealth Management bought 5 Alexion Pharmaceuticals shares in Q1 2016, an estimated $734.
Alexion Pharmaceuticals made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #762 holding.
Gupta Wealth Management first reported a position in Alexion Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
Gupta Wealth Management's Alexion Pharmaceuticals position peaked at $20K in Q4 2015.
520 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.